乙型肝炎病毒相关慢加急性肝衰竭患者肝纤维化、肝功能、病毒学指标及甲胎蛋白水平与预后的关系

张爱民; 游绍莉; 万志红; 孙志强; 刘鸿凌; 荣义辉; 朱冰; 辛绍杰

乙型肝炎病毒相关慢加急性肝衰竭患者肝纤维化、肝功能、病毒学指标及甲胎蛋白水平与预后的关系

解放军第三○二医院肝衰竭诊疗研究中心

详细信息

中图分类号: R512.62
计量
- 文章访问数: 183
- HTML全文浏览量: 8
- PDF下载量: 305
- 被引次数: 0
出版历程
- 出版日期: 2012-06-20

Relation of liver fibrosis indicators and prognosis in hepatitis B-related acute on chronic liver failure

摘要

摘要: 目的初步探讨乙型肝炎相关慢加急性肝衰竭（HBV-ACLF）患者血清肝纤维化、肝功能、病毒学指标及甲胎蛋白（AFP）水平与预后的关系。方法根据预后将185例HBV-ACLF患者分为好转组（116例）和无效组（69例）,检测血清肝纤维化和肝功能指标、病毒学指标、AFP水平,分析肝纤维化等指标与预后的关系。结果好转组和无效组性别、HBV基因型、HBeAg阳性率、HBV DNA载量、ALT、Alb、CHE比较差异无统计学意义。好转组和无效组平均年龄分别为（43.3±10.1）岁和（48.7±10.1）岁,TBil分别为（295.9±99.6）μmol/L、（355.4±136.8）μmol/L,凝血酶原活动度（PTA）分别为（34.5±7.9）%、（30.4±7.6）%,AFP分别为85（9～4760）ng/L、26（4～529）ng/L,差异皆有统计学意义（P值分别为0.006、0.009、0.0007、0.000）,肝纤维化指标中,透明质酸（HA）、Ⅲ型前胶原（PcⅢ）与Ⅳ型胶原（C-Ⅳ）好转组和无效组差异无统计学意义,层粘连蛋白（LN）好转组和无效组分别为657（45～1616）μg/L...
- 肝功能衰竭,急性 /
- 肝炎,乙型 /
- 肝硬化 /
- 预后
Abstract: Objective To study the relation of liver fibrosis indicators and prognosis in hepatitis B virus-related acute on chronic liver failure (HBV-ACLF) .Methods One-hundred-eighty-five cases of HBV-ACLF diagnosed and treated between October 2008 and October 2010 were classified according to prognosis: improved group (n=116) and ineffective group (n=69) .Serum markers of liver fibrosis, virus replication, and liver function were measured to analyze their relation with prognosis.Results There was no difference in sex, HBV genotype, positivity rate of HBV e antigen, HBV DNA load, or levels of alanine aminotransferase, albumin, cholinesterase, hyaluronic acid, type IV collagen, or human procollagen peptide III between the improved and ineffective groups.However, the improved group showed higher average age (years: 43.3±10.1 vs.ineffective group: 48.7±10.1, P=0.006) , level of total bilirubin (TBil;μmol/L: 295.9±99.6 vs.355.4±136.8, P=0.009) , prothrombin activity (PTA;%: 34.5±7.9 vs.ineffective group: 30.4 ±7.6 P=0.0007) , alpha-fetoprotein (AFP;ng/L: 85 (range: 9-4760) vs.ineffective group: 26 (4-529) , P<0.001) , and laminin (LN;μg/L: 657 (45-1616) vs.306 (29-1724) , P<0.001.Conclusion LN, AFP, TBil and PTA levels and age may be effective prognostic markers for HBV-ACLF patients.
- liver failure /
- acute /
- hepatitis B /
- liver cirrhosis

HTML全文

参考文献(5)

[1]Ananthakrishnan AN, McGinley EL, Saeian K.M1868 Uninsuredand medicaid patients have higher mortality in acute liver failure[J].Gastroenterology, 2008, 134 (4 Suppl 1) :A799-A800.

[2]黄明寿, 陈郁梅, 陈穗, 肝衰竭纤维化指标的动态观察和预后评估[J].中国现代医生, 2011, 49 (8) :36-37.

[3]中华医学会感染病学分会肝衰竭与人工肝学组、中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].中华内科杂志, 2006, 45 (12) :1053-1056.

[4]McClelland R, Wauthier E, Uronis J.et al.Gradients in the fiver’s extracellular matrix chemistry from periportal to pericentral zones:influence on human hepatic progenitors[J].Tissue Eng Part A, 2008, 14:59-70.

[5]李涛, 贾克东, 饶建锋.重型肝炎患者血清甲胎蛋白水平与预后的关系[J].实用临床医学, 2011, 12 (7) :19-20.

施引文献

资源附件(0)

访问统计